2004;10:942-9. Dao T, Scheinberg DA. Peptide vaccines for myeloid leukaemias. Best Pract Res Clin Haematol. 2008;21:391-404. SELLAS Life Sciences Group Galinpepimut -S Protocol : SLS17 -201/ MK3475 -770 Protocol v1.1 (Amendment 1.0) 12 April 2019 Page 236 Dao T, Korontsvit T, Zakhaleva V, et al. An immunogenic WT1-derived peptide that induces T cell response in the context of HLA -A*02:01 and HLA-A*24:02 molecules. Oncoimmunology. 2016;6:e1252895. Daver N, Basu S, Garcia-Manero G, et al. Phase IB/II study of nivolumab in combination with azacytidine (AZA) in patients with relapsed acute myeloid leukemia (AML). Proc 58th Ann Mtg Am Soc Hematol.